000			01927 a2200529 4500
005			20250517162749.0
264		0	_c20180702
008			201807s 0 0 eng d
022			_a1932-8737
024	7		_a10.1002/clc.22756 _2doi
040			_aNLM _beng _cNLM
100	1		_aJiang, Minghuan
245	0	0	_aCost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome. _h[electronic resource]
260			_bClinical cardiology _cOct 2017
300			_a789-796 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAcute Coronary Syndrome _xdiagnosis
650	0	4	_aAspirin _xadministration & dosage
650	0	4	_aClopidogrel
650	0	4	_aComputer Simulation
650	0	4	_aCoronary Thrombosis _xeconomics
650	0	4	_aCost-Benefit Analysis
650	0	4	_aDecision Trees
650	0	4	_aDisease-Free Survival
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Costs
650	0	4	_aDrug Therapy, Combination
650	0	4	_aDrug-Eluting Stents _xeconomics
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aModels, Economic
650	0	4	_aMonte Carlo Method
650	0	4	_aMyocardial Infarction _xeconomics
650	0	4	_aOdds Ratio
650	0	4	_aPercutaneous Coronary Intervention _xadverse effects
650	0	4	_aPlatelet Aggregation Inhibitors _xadministration & dosage
650	0	4	_aQuality-Adjusted Life Years
650	0	4	_aRisk Factors
650	0	4	_aStroke _xeconomics
650	0	4	_aTiclopidine _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aYou, Joyce H S
773	0		_tClinical cardiology _gvol. 40 _gno. 10 _gp. 789-796
856	4	0	_uhttps://doi.org/10.1002/clc.22756 _zAvailable from publisher's website
999			_c27343844 _d27343844